Ursodeoxycholic acid in the treatment of cholestasis of pregnancy: A randomized, double-blind study controlled with placebo

Journal of Hepatology

Volumn 27, Issue 6, 1997, Pages 1022-1028

  Palma, Joaquín ^a   Reyes, Humberto ^a,b   Ribalta, José ^a   Hernández, Ismael ^b   Sandoval, Lorena ^a   Almuna, Ramón ^a   Liepins, Juris ^a   Lira, Fernando ^a   Sedano, Manuel ^a   Silva, Octavio ^a   Tohá, Dolores ^a   Silva, Juan Jorge ^c  

^a UNIVERSITY OF CHILE   (Chile)

^b UNIVERSITY OF CHILE   (Chile)

^c NONE

Author keywords

Fetal distress; Hepatic pregnancy complications; Intrahepatic cholestasis; Ursodeoxycholic acid

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILE SALT; BILIRUBIN; CHOLESTEROL; GAMMA GLUTAMYLTRANSFERASE; PLACEBO; TRIACYLGLYCEROL; URSODEOXYCHOLIC ACID;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BIRTH WEIGHT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; FETUS DISTRESS; FETUS OUTCOME; HUMAN; INTRAHEPATIC CHOLESTASIS; ORAL DRUG ADMINISTRATION; PREGNANCY; PREMATURITY; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL;

EID: 0030730043     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(97)80146-8     Document Type: Article

References (42)

1. Svanborg A. A study of recurrent jaundice in pregnancy. Acta Obstet Gynecol Scand. 33:1954;434-444.
2. Reyes H. The enigma of intrahepatic cholestatis of pregnancy: lessons from Chile. Hepatology. 2:1982;87-96.
3. Reyes H, Radrigán ME, González MC, Latorre R, Ribalta J, Segovia N, et al. Steatorrhea in patients with intrahepatic cholestasis of pregnancy. Gastroenterology. 93:1987;584-590.
4. Reyes H. The spectrum of liver and gastrointestinal disease seen in cholestasis of pregnancy. Gastroeroenterol Clin North Am. 21:1992;905-921.
5. Reyes H, Simon FR. Intrahepatic cholestasis of pregnancy: an estrogen-related disease. Semin Liver Dis. 13:1993;289-301.
6. Roszkowski I, Pisarek-Miedzinska d. Jaundice in pregnancy. II Clinical course of pregnancy and delivery and condition of neonate. Am J Obstet Gynecol. 101:1968;500-503.
7. laatikainen T, Ikonen E. Fetal prognosis in obstetric hepatosis. Ann Chir Gynaecol Fenn. 64:1975;155-164.
8. Reid R, Ivey KJ, Rencoret RH, Storey B. Fetal complications of obstetric cholestasis. Br Med J. 1:1976;870-872.
9. Åmmälä P, Kariniemi V. Short-term variability of fetal heart rat in cholestasis of pregnancy. Am J Obstet Gynecol. 141:1981;217-220.
10. Laatikainen T, Tulenheimo A. Maternal serum bile acid levels and fetal distress in cholestasis of pregnancy. Int J Gynaecol Obstet. 22:1984;91-94.
11. Fisk NM, Storey GNB. Fetal outcome in obstetric cholestasis. Br J Obstet Gynaecol. 95:1988;1137-1143.
12. Rioseco AJ, Ivankovic MB, Manzur A, Hamed F, Kato SR, Parer JT, et al. Intrahepatic cholestasis of pregnancy. A retrospective case-control study of perinatal outcome. Am J Obstet Gynecol. 170:1994;890-895.
13. Acuña R, González MC. Hypoprothrombinemia and bleeding associated to treatment with cholestyramine. Rev Med Chile. 105:1977;27-28.
14. Sadler LC, Lane M, North R. Severe fetal intracranial haemorrhage during treatment with cholestyramine for intrahepatic cholestasis of pregnancy. Br J Obstet Gynaecol. 102:1955;169-170.
15. González MC, Iglesias J, Tiribelli C, Ribalta J, Reyes H, Hernández I. Epomedio ameliorates pruritus in patients with intrahepatic cholestasis of pregnancy. H Hepatol. 16:1992;241-242.
16. Frezza M, Pozzato G, Chiesa L, Stramentinoli G, Di Padova C. Reversal of intrahepatic cholestasis of pregnancy in women after high dose S-adenosyl-L-methionine administration. Hepatology. 4:1984;274-278.
17. Frezza M, Surrenti C, Manzillo G, Fiaccadori F, Bortolini M, Di Padova C. Oral S-Adenosylmethionine in the symptomatic treatment of intrahepatic cholestasis. A double-blind, placebo-controlled study. Gastroenterology. 99:1990;211-215.
18. Hirvioja ML, Tuimala R, Vuori J. The treatment of intrahepatic cholestasis of pregnancy by dexamethosone. Br J Obstet Gynaecol. 99:1992;109-111.
19. Kaaja RJ, Kontula KK, Raiha A, Laatikainen T. Treatment of Cholestasis of pregnancy with peroral activated charcoal. A preliminary study. Scand J Gastroenterol. 29:1994;178-181.
20. Ribalta J, Reyes H, González MC, Iglesias J, Arrese M, Poniachik J, et al. S-adenosyl-L-methionine in the treatment of patients with intrahepatic cholestasis of pregnancy: a randomized, double-blind, placebo controlled study with negative results. Hepatology. 13:1991;1084-1089.
21. Palma J, Reyes H, Ribalta J, Iglesias J, González MC, Hernández I, et al. Effects of ursodeoxycholic acid in patients with intrahepatic cholestasis of pregnancy. Paumgartner G, Stiehl A, Gerok W. Bile Acids as Therapeutic Agents: from Basic Science to clinical Practice. (Proceedings of the 58th Falk Symposium, Freiburg, Germany, October 11-13, 1990). 1991;319-322 Kluwer Academic Publishers, dordrecht.
22. Palma J, Reyes H, Ribalta J, Iglesias J, González M, Hernández I, et al. Effects of ursodeoxycholic acid in patients with intrahepatic cholestasis of pregnancy (preliminary report). Rev Med Chile. 119:1991;169-171.
23. Palma J, Reyes H, Ribalta J, Iglesias J, González MC, Hernández I, et al. Effects of sursodeoxycholic acid in patients with intrahepatic cholestasis of pregnancy. Hepatology. 15:1992;1043-1047.
24. Marpeau L, Chazouillière D, Rhimi Z, Poupon R, Pigne A, Barrat J. Pregnancy-associated idiopathic intrahepatic cholestasis. Hypothesis of physiopathology: a therapeutic case report. Fetal Diagn Ther. 6:1991;120-125.
25. Mazella G, Rizzo N, Salzetta A, Iampieri R, Bovicelli L, Roda E. Management of intrahepatic cholestasis in pregnancy. Lancet. 339:1991;1594-1595.
26. Brites D, Poeiras J, Rodriguez C. Intrahepatic cholestasis of pregnancy: etiopathogenesis, prognosis and treatment. Acta Med Port. 7:1994;181-188.
27. Floreani A, Paternoster D, Grella V, Sacco S, Gangemi M, Chiaramonte M. Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy. Br J Obstet Gynaecol. 101:1994;64-65.
28. Davies MH, da Silva RCMA, Jones SR, Weaver JB, Elias E. Fetal mortality associated with cholestasis of pregnancy and the potential benefit of therapy with ursodeoxycholic acid. Gut. 37:1995;580-584.
29. Glantz SA. 3rd ed Primer of Biostatistics. 1992;McGraw-Hill, Inc. New York.
30. Sepúlveda WH, González C, Cruz MA, Rudolph MI. Vasoconstrictive effect of the bile acides on isolated human placental chorionic veins. Eur J Obstet Gynaecol Reprod Biol. 42:1991;211-215.
31. Dubner H, Fromm H. Ursodeoxycholic acid treatment of intrahepatic cholestasis of pregnancy: observations on efficacy and safety. Gastroenterology. 104:1993;660-661.
32. Meng LJ, Reyes H, Palma J, Hernández I, Ribalta J, Sjövall J. Profiles of bile acids and progesterone metabolites in the urine and serum of women with intrahepatic cholestasis of pregnancy. J Hepatol. 27:1997;346-357.
33. Sjövall K, Sjövall J. Serum bile acid levels in pregnancy with pruritus. Clin Chim Acta. 13:1966;207-211.
34. Heikkinen J, Mäenmtausta O, Ylöstalo P, Jänne O. Serum bile acid levels in intrahepatic cholestasis of pregnancy during treatment with phenobarbital or cholestyramine. Eur J Obstet Reprod Biol. 14:1982;153-162.
35. Meng LJ, Reyes H, Palma J, Hernández I, Ribalta J, Sjövall J. Profiles of steroids and bile acids in plasma of patients with intrahepatic cholestasis of pregnancy - effect or ursodeoxycholic acid therapy. van Berge Henegouwen GP, van Hoek B, de Groote J, Matern S, Stockbrügger RW. Cholestatic Liver Diseases. 45-49:1994;Kluwer Academic Publishers, Dordrecht.
36. Meng LJ, Reyes H, Palma J, Hernández I, Ribala J, Sjövall J. Progesterone metabolism in normal human pregnancy and in patients with intrahepatic cholestasis of pregnancy. Reyes HB, Leuschner U, Arias IM. Pregnancy, Sex Hormones and the Liver. 1996;91-100 Kluwer Academic Publishers, Dordrecht.
37. Bacq Y, Myara A, Brechot M-C, Hamon C, Studer E, Trivin F, et al. Serum conjugated bile acid profile during intrahepatic cholestasis of pregnacy. J Hepatl. 22:1995;66-70.
38. Hoffmann AF. Bile acid hepatotoxicity and the rationale of UDCA therapy in chronic cholestatic liver disease: some hypothesis. Paumgartner G, Stiehl A, Barbara L, Roda E. Strategies for the Treatment of Hepatobiliary Diseases. 1990;13-34 Kluwer Academic, Dordrecht.
39. Beuers U, Spengler U, Zwiebel FM, Pauletzki J, Fisher S, Paumgartner G. Effect of ursodeoxycholic acid on the kinetics of the major hydrophobic bile acids in health and in chronic cholestatic liver disease. Hepatology. 15:1992;603-608.
40. ++ mechanisms defective in cholestasis. J Clin Invest. 92:1993;2984-2993.
41. Beyer JL, Soroka CJ. Vescile targeting to the apical domain regulates bile excretory function in isolated rat hepatocyte couplets. Gastroenterology. 109:1995;1600-1611.
42. Beuers U, Throckmorton DC, Anderson MS, Isales CM, Thasler W, Kullak-Ublick GA, et al. Tauroursodeoxycholic acid activates protein kinase C in isolated rat hepatocytes. Gastroenterology. 110:1996;1553-1563.